India to Sri Lanka: Ranitidine Export Trade Route
India has recorded 54 verified shipments of Ranitidine exported to Sri Lanka, representing a combined trade value of $444.1K USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $8.2K USD. The leading Indian exporter is CADILA PHARMACEUTICALS LIMITED, which accounts for 58% of total export value with 27 shipments worth $256.3K USD. On the buying side, SUNSHINE HEALTHCARE LANKA LIMITED is the largest importer in Sri Lanka with $105.6K USD in purchases. The top 3 suppliers — CADILA PHARMACEUTICALS LIMITED, PHARMAFABRIKON, CADILA PHARMACEUTICALS LIMITED — together control 81% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Sri Lanka Ranitidine corridor is one of India's established pharmaceutical export routes, with 54 shipments documented worth a combined $444.1K USD. The route is dominated by CADILA PHARMACEUTICALS LIMITED, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's ranitidine manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $8.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with ranitidine's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 16.0%, placing it at rank #7 among India's top ranitidine export destinations globally.
On the import side, key buyers of Indian ranitidine in Sri Lanka include SUNSHINE HEALTHCARE LANKA LIMITED, .SUNSHINE HEALTHCARE LANKA LIMITED, SUNSHINE HEALTHCARE LANKA LIMITED. and 16 others. SUNSHINE HEALTHCARE LANKA LIMITED is the single largest importer with 19 shipments valued at $105.6K USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ1
- Primary modeSea freight
- Top portAHEMDABAD ICD
Market Position
- Global rank#7
- Annual growth+16.0%
- Demand growth+15.8%
- Regulatory ease83/100
Top 10 Indian Ranitidine Exporters to Sri Lanka
Showing top 10 of 11 Indian suppliers exporting Ranitidine to Sri Lanka, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CADILA PHARMACEUTICALS LIMITED Avg $9.5K per shipment | 27 | $256.3K | 57.7% |
| 2 | PHARMAFABRIKON Avg $28.3K per shipment | 2 | $56.5K | 12.7% |
| 3 | CADILA PHARMACEUTICALS LIMITED Avg $9.8K per shipment | 5 | $48.8K | 11.0% |
| 4 | PHARMAFABRIKON Avg $35.6K per shipment | 1 | $35.6K | 8.0% |
| 5 | MAXTAR BIO GENICS Avg $27.7K per shipment | 1 | $27.7K | 6.2% |
| 6 | BELCO PHARMA Avg $2.1K per shipment | 8 | $17.1K | 3.9% |
| 7 | ASPAR PHARMACEUTICALS Avg $246 per shipment | 5 | $1.2K | 0.3% |
| 8 | PLEASANT EXPORTS Avg $289 per shipment | 2 | $578 | 0.1% |
| 9 | ASPAR PHARMACEUTICALS Avg $147 per shipment | 1 | $147 | 0.0% |
| 10 | MEDMALL PHARMACY PRIVATE LIMITED Avg $50 per shipment | 1 | $50 | 0.0% |
This table shows the top 10 of 11 Indian companies exporting ranitidine to Sri Lanka, ranked by total trade value. The listed exporters are: CADILA PHARMACEUTICALS LIMITED, PHARMAFABRIKON, CADILA PHARMACEUTICALS LIMITED , PHARMAFABRIKON , MAXTAR BIO GENICS, BELCO PHARMA, ASPAR PHARMACEUTICALS , PLEASANT EXPORTS, ASPAR PHARMACEUTICALS, MEDMALL PHARMACY PRIVATE LIMITED . CADILA PHARMACEUTICALS LIMITED is the dominant supplier with 27 shipments worth $256.3K USD, giving it a 58% market share. The top 3 suppliers together account for 81% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to Sri Lanka Ranitidine export route.
Top 10 Ranitidine Importers in Sri Lanka
Showing top 10 of 19 known buyers in Sri Lanka receiving Ranitidine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ranitidine in Sri Lanka include SUNSHINE HEALTHCARE LANKA LIMITED, .SUNSHINE HEALTHCARE LANKA LIMITED, SUNSHINE HEALTHCARE LANKA LIMITED., SUNSHINE HEALTHCARE LANKA LIMITED , M/S.STATE PHARMACEUTICALS , among 19 total buyers. The largest importer is SUNSHINE HEALTHCARE LANKA LIMITED, accounting for $105.6K USD across 19 shipments — representing 24% of all ranitidine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUNSHINE HEALTHCARE LANKA LIMITED | 19 | $105.6K | 23.8% |
| 2 | .SUNSHINE HEALTHCARE LANKA LIMITED | 4 | $93.9K | 21.1% |
| 3 | SUNSHINE HEALTHCARE LANKA LIMITED. | 4 | $56.9K | 12.8% |
| 4 | SUNSHINE HEALTHCARE LANKA LIMITED | 5 | $48.8K | 11.0% |
| 5 | M/S.STATE PHARMACEUTICALS | 1 | $35.6K | 8.0% |
| 6 | M/S.STATE PHARMACETICALS | 1 | $32.8K | 7.4% |
| 7 | PHARMA ASSOCIATES | 1 | $27.7K | 6.2% |
| 8 | M SSTATE PHARMACETICALS CORPORATION | 1 | $23.7K | 5.3% |
| 9 | TO THE ORDER | 1 | $6.2K | 1.4% |
| 10 | NA | 1 | $4.1K | 0.9% |
Showing top 10 of 19 Ranitidine importers in Sri Lanka on this route.
Top 10 Ranitidine Formulations Imported by Sri Lanka
Showing top 10 of 38 product formulations shipped on the India to Sri Lanka Ranitidine route, ranked by trade value
Sri Lanka imports a wide range of ranitidine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHA DRG & MED ACILOC 150 CONT. RANITIDINE HCL TABLETS USP (150MG) QTY. 100T/PAC — accounts for $99.6K USD across 6 shipments. There are 38 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHA DRG & MED ACILOC 150 CONT. RANITIDINE HCL TABLETS USP (150MG) QTY. 100T/PAC | 6 | $99.6K | 22.4% |
| 2 | PHA DRG & MED ACILOC 150 TAB. CONT. RANITIDINE HCL TABLETS USP (150MG) QTY. 100T/PAC | 2 | $73.6K | 16.6% |
| 3 | RANITIDINE INJECTION BP 25 MG/2 ML AMPO | 1 | $35.6K | 8.0% |
| 4 | 600,000 AMPOULES (6,000P X 100`S)RANITIDINE INJECTION BP 25MG/ML AMPOULE | 1 | $32.8K | 7.4% |
| 5 | (Pharmaceutical Products-Medicines)Ranitidine Tablets BP 150mg B/NO. MF5AC2403,MF5AC2404 M/DT. 11/2024 E/DT. 10/2027 | 1 | $27.7K | 6.2% |
| 6 | ACILOC 150 (R/M : RANITIDINE HCL TABLETS USP (150MG) BATCH N683005B/N68E3006 MFG DT-NOV-2023 EXP DT-OCT-2026 | 1 | $27.4K | 6.2% |
| 7 | 500,000 AMPOULES 5,000P X 100`S RANITIDINE INJECTION BP 25MG/ML 2ML AMPOULE | 1 | $23.7K | 5.3% |
| 8 | ACILOC 150 (R/M : RANITIDINE HCL TABLETS | 2 | $23.6K | 5.3% |
| 9 | ACILOC 150 ( RAW MATERIAL : RANITIDINE H | 1 | $17.2K | 3.9% |
| 10 | PHA DRG & MED ACILOC 150 TAB. CONT. RANITIDINE HCL TABLETS USP 150MG QTY. 100T/PAC | 1 | $13.8K | 3.1% |
Showing top 10 of 38 Ranitidine formulations imported by Sri Lanka on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
AHEMDABAD ICD handles the highest volume with 12 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's ranitidine exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. CADILA PHARMACEUTICALS LIMITED with 27 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CADILA PHARMACEUTICALS LIMITED, PHARMAFABRIKON, CADILA PHARMACEUTICALS LIMITED — together account for 81% of total trade value on this route. The average shipment value of $8.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pha drg & med aciloc 150 tab. cont. ranitidine hcl tablets usp (150mg) qty. 100t/pac and ranitidine injection bp 25 mg/2 ml ampo , suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUNSHINE HEALTHCARE LANKA LIMITED is the largest importer with 19 shipments worth $105.6K USD — representing 24% of all ranitidine imports from India on this route. A total of 19 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $444.1K
- Avg. Shipment
- $8.2K
- Suppliers
- 11
- Buyers
- 19
- Transit (Sea)
- ~17 days
- Annual Growth
- +16.0%
Related Analysis
Other Ranitidine Routes
Unlock the Full India to Sri Lanka Ranitidine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 54 shipments on this route.
Frequently Asked Questions — India to Sri Lanka Ranitidine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ranitidine to Sri Lanka?
The leading Indian exporters of Ranitidine to Sri Lanka are CADILA PHARMACEUTICALS LIMITED, PHARMAFABRIKON, CADILA PHARMACEUTICALS LIMITED . CADILA PHARMACEUTICALS LIMITED holds the largest market share at approximately 58% of total trade value on this route.
Q What is the total value of Ranitidine exports from India to Sri Lanka?
India exports Ranitidine to Sri Lanka worth approximately $444.1K USD across 54 recorded shipments. The average value per shipment is $8.2K USD.
Q Which ports does India use to ship Ranitidine to Sri Lanka?
The most active port of origin is AHEMDABAD ICD with 12 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Sri Lanka for Ranitidine?
The average transit time for Ranitidine shipments from India to Sri Lanka is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Sri Lanka Ranitidine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 16.0% with demand growth tracking at 15.8%. The route is ranked #7 among India's top Ranitidine export destinations globally.
Q How many suppliers are active on the India to Sri Lanka Ranitidine route?
There are currently 11 active Indian suppliers exporting Ranitidine to Sri Lanka. The market is moderately concentrated with CADILA PHARMACEUTICALS LIMITED accounting for 58% of total shipment value.
Q Who are the main importers of Ranitidine from India in Sri Lanka?
The leading importers of Indian Ranitidine in Sri Lanka include SUNSHINE HEALTHCARE LANKA LIMITED, .SUNSHINE HEALTHCARE LANKA LIMITED, SUNSHINE HEALTHCARE LANKA LIMITED., SUNSHINE HEALTHCARE LANKA LIMITED , M/S.STATE PHARMACEUTICALS . SUNSHINE HEALTHCARE LANKA LIMITED is the largest buyer with 19 shipments worth $105.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Sri Lanka export trade corridor identified from Indian Customs (DGFT) records for Ranitidine.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 19 importers in Sri Lanka matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 54 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
54 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists